Nipanshi Tyagi is a researcher in cancer biology with a strong focus on understanding and overcoming drug resistance in leukemia. Her work focuses on developing early diagnostic approaches to predict response to tyrosine kinase inhibitors, particularly in chronic myeloid leukemia. She has hands-on expertise in cell culture, PBMC isolation, molecular biology, nanotechnology, and bioinformatics. Nipanshi has contributed to peer-reviewed publications and is actively engaged in translational research aimed at improving personalized cancer therapy. Through her interdisciplinary approach, she strives to bridge laboratory findings with clinical application, enhancing treatment outcomes and patient care.
CRDWC 2026
Oral Presentation